Biofrontera AG engages in the research, development, and marketing of dermatological products. Its products include Ameluz, BF-RhodolesXepi and Belixos. The company was founded by Hermann Lübbert in 1997 and is headquartered in Leverkusen, Germany.
The current price of BFFTF is 1.08 USD — it has decreased by 20.00% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Biofrontera AG stocks are traded under the ticker BFFTF.
Biofrontera AG is going to release the next earnings report on Apr 25, 2024. Keep track of upcoming events with our Earnings Calendar.
BFFTF stock is 25.00% volatile and has beta coefficient of 0.34. Check out the list of the most volatile stocks — is Biofrontera AG there?
BFFTF earnings for the last quarter are −0.08 USD per share, whereas the estimation was −0.11 USD resulting in a 25.29% surprise. The estimated earnings for the next quarter are −0.09 USD per share. See more details about Biofrontera AG earnings.
Biofrontera AG revenue for the last quarter amounts to 9.14 M USD despite the estimated figure of 7.11 M USD. In the next quarter revenue is expected to reach 7.88 M USD.
Today Biofrontera AG has the market capitalization of 21.19 M, it has decreased by 2.90% over the last week.
No, BFFTF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, BFFTF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Biofrontera AG stock right from TradingView charts — choose your broker and connect to your account.
BFFTF reached its all-time high on Mar 12, 2018 with the price of 8.22 USD, and its all-time low was 1.08 USD and was reached on May 30, 2023. See other stocks reaching their highest and lowest prices.
As of Apr 20, 2024, the company has 110.00 employees. See our rating of the largest employees — is Biofrontera AG on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Biofrontera AG technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Biofrontera AG stock shows the sell signal. See more of Biofrontera AG technicals for a more comprehensive analysis. If you're still not sure, try looking for inspiration in our curated watchlists.